The author suggests three ways Congress should act to make life-altering medications affordable for Americans.
Most people first notice pill bugs while lifting a flowerpot or turning over a log, then watching small gray roly polies curl ...
The funding will support a GLP-1 pill Corxel licensed from China-based Vincentage in 2024 and that the company believes to be ...
Asthma is one of the most prevalent chronic inflammatory respiratory diseases across the globe, with a significant increase ...
Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. Join Cupid Crew in sending love this Valentine’s Day Help ...
Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...
Dec. 30, 2025 – updated Jan. 5, 2026 – Injectable GLP-1 drugs have transformed obesity treatment – and now they're going oral. "It's good to have more options for patients with obesity," said Melanie ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Novo Nordisk plans to ...
This is read by an automated voice. Please report any issues or inconsistencies here. U.S. regulators this week gave the green light to a pill version of the ...
The FDA has approved a pill form of the popular GLP-1 weight-loss medication George Frey/Bloomberg via Getty The U.S. Food and Drug Administration has approved the pill form of Wegovy, the weight-loss ...
Regulators at the U.S. Food and Drug Administration on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. The ...
U.S. regulators on Monday gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity. For years, GLP-1 medications like Novo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results